{
    "q": [
        {
            "docid": "3043886_66",
            "document": "Enzyme kinetics . The favoured model for the enzyme\u2013substrate interaction is the induced fit model. This model proposes that the initial interaction between enzyme and substrate is relatively weak, but that these weak interactions rapidly induce conformational changes in the enzyme that strengthen binding. These conformational changes also bring catalytic residues in the active site close to the chemical bonds in the substrate that will be altered in the reaction. Conformational changes can be measured using circular dichroism or dual polarisation interferometry. After binding takes place, one or more mechanisms of catalysis lower the energy of the reaction's transition state by providing an alternative chemical pathway for the reaction. Mechanisms of catalysis include catalysis by bond strain; by proximity and orientation; by active-site proton donors or acceptors; covalent catalysis and quantum tunnelling.",
            "score": 109.03271317481995
        },
        {
            "docid": "188688_10",
            "document": "Active site . Daniel Koshland's theory of enzyme-substrate binding is that the active site and the binding portion of the substrate are not exactly complementary. The induced fit model is a development of the lock-and-key model and assumes that an active site is flexible and changes shape until the substrate is completely bound. This model is similar to a person wearing a glove: it changes shape to fit the hand. The enzyme initially has a configuration that attracts its substrate. Enzyme surface is flexible and only the correct catalyst can induce interaction leading to catalysis. Conformational changes may then occur as the substrate is bound. After the reaction products will move away from the enzyme and the active site returns to its initial shape. This hypothesis is supported by the observation that the entire protein domain could move several nanometers during catalysis. This movement of protein surface can create microenvironments that favour the catalysis.",
            "score": 99.69318664073944
        },
        {
            "docid": "342457_11",
            "document": "Cellulase . Both binding of substrates and catalysis depend on the three-dimensional structure of the enzyme which arises as a consequence of the level of protein folding. The amino acid sequence and arrangement of their residues that occur within the active site, the position where the substrate binds, may influence factors like binding affinity of ligands, stabilization of substrates within the active site and catalysis. The substrate structure is complementary to the precise active site structure of enzyme. Changes in the position of residues may result in distortion of one or more of these interactions. Additional factors like temperature, pH and metal ions influence the non-covalent interactions between enzyme structure. The Thermotoga maritima species make cellulases consisting of 2 beta-sheets (protein structures) surrounding a central catalytic region which is the active-site. The enzyme is categorised as an endoglucanase, which internally cleaves \u03b2-1,4 -glycosydic bonds in cellulose chains facilitating further degradation of the polymer. Different species in the same family as T. Maritima make cellulases with different structures. Cellulases produced by the species Coprinopsis Cinerea consists of seven protein strands in the shape of an enclosed tunnel called a beta/alpha barrel. These enzymes hydrolyse the substrate carboxymethyl cellulose. Binding of the substrate in the active site induces a change in conformation which allows degradation of the molecule.",
            "score": 107.47722721099854
        },
        {
            "docid": "7137983_5",
            "document": "Enzyme catalysis . The advantages of the induced fit mechanism arise due to the stabilizing effect of strong enzyme binding. There are two different mechanisms of substrate binding: uniform binding, which has strong substrate binding, and differential binding, which has strong transition state binding. The stabilizing effect of uniform binding increases both substrate and transition state binding affinity, while differential binding increases only transition state binding affinity. Both are used by enzymes and have been evolutionarily chosen to minimize the activation energy of the reaction. Enzymes that are saturated, that is, have a high affinity substrate binding, require differential binding to reduce the energy of activation, whereas small substrate unbound enzymes may use either differential or uniform binding.",
            "score": 83.08243894577026
        },
        {
            "docid": "7137983_6",
            "document": "Enzyme catalysis . These effects have led to most proteins using the differential binding mechanism to reduce the energy of activation, so most substrates have high affinity for the enzyme while in the transition state. Differential binding is carried out by the induced fit mechanism - the substrate first binds weakly, then the enzyme changes conformation increasing the affinity to the transition state and stabilizing it, so reducing the activation energy to reach it.",
            "score": 89.2582790851593
        },
        {
            "docid": "9257_24",
            "document": "Enzyme . In 1958, Daniel Koshland suggested a modification to the lock and key model: since enzymes are rather flexible structures, the active site is continuously reshaped by interactions with the substrate as the substrate interacts with the enzyme. As a result, the substrate does not simply bind to a rigid active site; the amino acid side-chains that make up the active site are molded into the precise positions that enable the enzyme to perform its catalytic function. In some cases, such as glycosidases, the substrate molecule also changes shape slightly as it enters the active site. The active site continues to change until the substrate is completely bound, at which point the final shape and charge distribution is determined. Induced fit may enhance the fidelity of molecular recognition in the presence of competition and noise via the conformational proofreading mechanism.",
            "score": 89.81246173381805
        },
        {
            "docid": "14216616_7",
            "document": "Phosphoenolpyruvate mutase . However, more recently, a structure with a sulfopyruvate inhibitor, which is a closer substrate analogue, was solved (); this study supported instead a dissociative mechanism. A notable feature of these structures was the shielding of the active site from solvent; it was proposed that a significant conformational change takes place on binding to allow this, moving the protein from an \"open\" to a \"closed\" state, and this was supported by several crystal structures in the open state. Three of these were of the wild type: the apoenzyme in , the enzyme plus its magnesium ion cofactor in , and the enzyme at high ionic strength in . A mutant (D58A, in one of the active-site loops) was crystallized as an apoenzyme also (). From these structures, an active-site \"gating\" loop (residues 115-133) that shields the substrate from solvent in the closed conformation was identified.",
            "score": 93.33669519424438
        },
        {
            "docid": "39192470_7",
            "document": "Soluble adenylyl cyclase . The open conformation state of sAC is reached when ATP, with Ca bound to its \u03b3-phosphate binds with specific residues in the catalytic center of the enzyme. When the second metal \u2013 a Mg ion \u2013 binds to the \u03b1-phosphate of ATP leads to a conformational change of the enzyme: \"the close state\". The change in conformation from open to close state induces esterification of the \u03b1-phosphate with the ribose in adenosine and the release of the \u03b2- and \u03b3-phosphates, this leads to cyclizing. Hydrogencarbonate stimulates the enzyme\u2019s V by promoting the allosteric change that leads to active site closure, recruitment of the catalytic Mg ion, and readjustment of the phosphates in the bound ATP. The activator bicarbonate binds to a site pseudo-symmetric to the active site and triggers conformational changes by recruiting Arg176 from the active site (see above - \"structure\"). Calcium increases substrate affinity by replacing the magnesium in the ion B site, which provides an anchoring point for the beta- and gamma-phosphates of the ATP substrate.",
            "score": 107.67993545532227
        },
        {
            "docid": "8368304_5",
            "document": "Sequential model . The KNF model follows the structural theory of the induced fit model of substrate binding to an enzyme. A slight change in the conformation of an enzyme improves its binding affinity to the transition state of the ligand, thus catalyzing a reaction. This follows the KNF model, which models cooperativity as the changing conformation of the ligand binding site upon ligand binding to another subunit.",
            "score": 102.06386685371399
        },
        {
            "docid": "1551873_21",
            "document": "ATP-binding cassette transporter . The general mechanism for the transport cycle of ABC transporters has not been fully elucidated but substantial structural and biochemical data has accumulated to support a model in which ATP binding and hydrolysis is coupled to conformational changes in the transporter. The resting state of all ABC transporters has the NBDs in an open dimer configuration, with low affinity for ATP. This open conformation possesses a chamber accessible to the interior of the transporter. The transport cycle is initiated by binding of substrate to the high-affinity site on the TMDs, which induces conformational changes in the NBDs and enhances the binding of ATP. Two molecules of ATP bind, cooperatively, to form the closed dimer configuration. The closed NBD dimer induces a conformational change in the TMDs such that the TMD opens, forming a chamber with an opening opposite to that of the initial state. The affinity of the substrate to the TMD is reduced, thereby releasing the substrate. Hydrolysis of ATP follows and then sequential release of P and then ADP restores the transporter to its basal configuration. Although a common mechanism has been suggested, the order of substrate binding, nucleotide binding and hydrolysis, and conformational changes, as well as interactions between the domains is still debated.",
            "score": 75.91710257530212
        },
        {
            "docid": "13901085_5",
            "document": "Malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) . Based on crystallography data of homologous NADP-dependent malic enzymes of mammalian origin, a 3D model for C pathway NADP-ME in plants has been developed, identifying the key residues involved in substrate-binding or catalysis. Dinucleotide binding involves two glycine rich GXGXXG motifs, a hydrophobic groove involving at least six amino acid residues, and a negatively charged residue at the end of the \u03b2B-strand. The primary sequence of the first motif, GLGDLG, is a consensus marker for phosphate binding, evidencing involvement with NADP binding, while the other glycine rich motif adopts a classical Rossman fold\u2014also a typical marker for NADP cofactor binding. Mutagenesis experiments in maize NADP-ME have supported the current model. Valine substitution for glycine in either motif region rendered the enzyme completely inactive while spectral analysis indicated no major changes from wild-type form. The data is suggestive of direct impairment at a key residue involved in binding or catalysis rather than an inter-domain residue influencing conformational stability.  Additionally, a key arginine residue at site 237 has been shown to interact both with malate and NADP substrates, forming key favorable electrostatic interactions to the negatively charged carboxylic-acid and phosphate group respectively. Elucidation of whether the residue plays a role in substrate binding or substrate positioning for catalysis has yet to be determined.  Lysine residue 255 has been implicated as a catalytic base for the enzymes reactivity; however, further studies are still required to conclusively establish its biochemical role.",
            "score": 87.4550359249115
        },
        {
            "docid": "2764033_12",
            "document": "DNA polymerase II . Upon binding of substrate, DNA Pol II binds nucleoside triphosphates to maintain the hydrogen bonded structure of DNA. The correct dNTP is then bound and the enzyme complex undergoes conformational changes of subdomains and amino acid residues. These conformational changes allow the rate of repair synthesis to be fast. The active site contains two Mg ions that are stabilized by catalytic Aspartic Acids D419 and D547. Magnesium ions bind to DNA along with dNTP in the open state and coordinate conformational changes of active site amino acid residues in order for catalysis to take place (closed state). After magnesium ions are released, the enzyme returns to its open state.",
            "score": 95.99395418167114
        },
        {
            "docid": "7137983_25",
            "document": "Enzyme catalysis . This is the principal effect of induced fit binding, where the affinity of the enzyme to the transition state is greater than to the substrate itself. This induces structural rearrangements which strain substrate bonds into a position closer to the conformation of the transition state, so lowering the energy difference between the substrate and transition state and helping catalyze the reaction.",
            "score": 79.6452260017395
        },
        {
            "docid": "54970639_9",
            "document": "Thimet oligopeptidase . TOP1 plays a role in the pathway for degradation of unneeded peptides during importation of proteins to mitochondria and chloroplasts. This function can be explained due to changes in the closed conformation of TOP1 structure. The spheroidal shape, generating by the domains I and II, represents the catalytic cavity with a volume of \u223c3,000 \u00c5. During the peptide degradation, the substrate binding can occur only if there is a separation of the two domains allowing the access and binding of the free targeting peptides to the cavity (active site). The enzyme substrate complex is maintained by several non-covalent interactions: hydrophobic and polar interactions. The process is limited by the peptide size. Thus, only peptides with approximately the same volume (\u223c3,000 \u00c5) can be degraded by the enzyme. Peptides that can be cleaved off are between 8 to 23 amino-acid residues.",
            "score": 87.24982452392578
        },
        {
            "docid": "7137983_9",
            "document": "Enzyme catalysis . These conformational changes also bring catalytic residues in the active site close to the chemical bonds in the substrate that will be altered in the reaction. After binding takes place, one or more mechanisms of catalysis lowers the energy of the reaction's transition state, by providing an alternative chemical pathway for the reaction. There are six possible mechanisms of \"over the barrier\" catalysis as well as a \"through the barrier\" mechanism:",
            "score": 77.10819482803345
        },
        {
            "docid": "1406208_3",
            "document": "GroEL . Within the cell, the process of GroEL/ES mediated protein folding involves multiple rounds of binding, encapsulation, and release of substrate protein. Unfolded substrate proteins bind to a hydrophobic binding patch on the interior rim of the open cavity of GroEL, forming a binary complex with the chaperonin. Binding of substrate protein in this manner, in addition to binding of ATP, induces a conformational change that allows association of the binary complex with a separate lid structure, GroES. Binding of GroES to the open cavity of the chaperonin induces the individual subunits of the chaperonin to rotate such that the hydrophobic substrate binding site is removed from the interior of the cavity, causing the substrate protein to be ejected from the rim into the now largely hydrophilic chamber. The hydrophilic environment of the chamber favors the burying of hydrophobic residues of the substrate, inducing substrate folding. Hydrolysis of ATP and binding of a new substrate protein to the opposite cavity sends an allosteric signal causing GroES and the encapsulated protein to be released into the cytosol. A given protein will undergo multiple rounds of folding, returning each time to its original unfolded state, until the native conformation or an intermediate structure committed to reaching the native state is achieved. Alternatively, the substrate may succumb to a competing reaction, such as misfolding and aggregation with other misfolded proteins.",
            "score": 77.0678198337555
        },
        {
            "docid": "7137983_4",
            "document": "Enzyme catalysis . The favored model for the enzyme-substrate interaction is the induced fit model. This model proposes that the initial interaction between enzyme and substrate is relatively weak, but that these weak interactions rapidly induce conformational changes in the enzyme that strengthen binding.",
            "score": 81.79665422439575
        },
        {
            "docid": "1375635_9",
            "document": "Adenylate kinase . The local (thermodynamic) stability of the substrate-binding domains ATP and AMP has been shown to be significantly lower when compared with the CORE domain in ADK. Furthermore, it has been shown that the two subdomains (ATP and AMP) can fold and unfold in a \"non-cooperative manner.\" Binding of the substrates causes preference for 'closed' conformations amongst those that are sampled by ADK. These 'closed' conformations are hypothesized to help with removal of water from the active site to avoid wasteful hydrolysis of ATP in addition to helping optimize alignment of substrates for phosphoryl-transfer. Furthermore, it has been shown that the apoenzyme will still sample the 'closed' conformations of the ATP and AMP domains in the absence of substrates. When comparing the rate of opening of the enzyme (which allows for product release) and the rate of closing that accompanies substrate binding, closing was found to be the slower process.",
            "score": 74.30448079109192
        },
        {
            "docid": "106256_13",
            "document": "Allosteric regulation . Allosteric modulation is commonly used to alter the activity of molecules and enzymes in biochemistry and pharmacology. For example, drugs are made to bind to the active site of the enzyme which inhibit the substrates to bind to the enzyme and perform the reaction. Allosteric modulation occurs when a specific ligand binds to the allosteric site (also known as the regulatory site) of the enzyme and alters the drugs' effects on the substrates by either activating or inhibiting the enzyme activity. Allosteric modulators are designed to fit the allosteric site to cause conformational changes of the enzyme by changing the shape of the active site which causes a change in its activity. They work regardless of the fact that the enzyme substrate was able to bind to the active site or not. They can be positive,(activating) causing an increase of the enzyme activity, or they can be negative (inhibiting) causing a decrease of the enzyme activity. The use of allosteric modulation allows the control of the effects of specific enzyme activities, as a result, allosteric modulators are very effective in pharmacology.",
            "score": 112.07910668849945
        },
        {
            "docid": "106256_8",
            "document": "Allosteric regulation . The sequential model of allosteric regulation holds that subunits are not connected in such a way that a conformational change in one induces a similar change in the others. Thus, all enzyme subunits do not necessitate the same conformation. Moreover, the sequential model dictates that molecules of a substrate bind via an induced fit protocol. In general, when a subunit randomly collides with a molecule of substrate, the active site, in essence, forms a glove around its substrate. While such an induced fit converts a subunit from the tensed state to relaxed state, it does not propagate the conformational change to adjacent subunits. Instead, substrate-binding at one subunit only slightly alters the structure of other subunits so that their binding sites are more receptive to substrate. To summarize:",
            "score": 89.27581286430359
        },
        {
            "docid": "13897682_10",
            "document": "Shikimate dehydrogenase . The Structure of Shikimate dehydrogenase is characterized by two domains, two alpha helices and two beta sheets with a large cleft separating the domains of the monomer. The enzyme is symmetrical. Shikimate dehydrogenase also has an NADPH binding site that contains a Rossmann fold. This binding site normally contains a glycine P-loop. The domains of the monomer show a fair amount of flexibility suggesting that the enzyme can open in close to bind with the substrate 3-Dehydroshikimate. Hydrophobic interactions occur between the domains and the NADPH binding site. This hydrophobic core and its interactions lock the shape of the enzyme even though the enzyme is a dynamic structure. There is also evidence to support that the structure of the enzyme is conserved, meaning the structure takes sharp turns in order to take up less space.",
            "score": 74.23409032821655
        },
        {
            "docid": "188688_44",
            "document": "Active site . Identification of active sites is crucial in the process of drug discovery. The 3-D structure of the enzyme is analysed to identify active sites and design drugs which can fit into them. Proteolytic enzymes are targets for some drugs, such as protease inhibitors, which include drugs against AIDS and hypertension. These protease inhibitors bind to an enzyme's active site and block interaction with natural substrates. An important factor in drug design is the strength of binding between the active site and an enzyme inhibitor. If the enzyme found in bacteria is significantly different from the human enzyme then an inhibitor can be designed against that particular bacterium without harming the human enzyme. If one kind of enzyme is only present in one kind of organism, its inhibitor can be used to specifically wipe them out.",
            "score": 89.42715835571289
        },
        {
            "docid": "1551873_23",
            "document": "ATP-binding cassette transporter . Some evidence to show that ATP binding is indeed the power stroke of the transport cycle was reported. It has been shown that ATP binding induces changes in the substrate-binding properties of the TMDs. The affinity of ABC transporters for substrates has been difficult to measure directly, and indirect measurements, for instance through stimulation of ATPase activity, often reflects other rate-limiting steps. Recently, direct measurement of vinblastine binding to permease-glycoprotein (P-glycoprotein) in the presence of nonhydrolyzable ATP analogs, e.g. 5\u2019-adenylyl-\u03b2-\u03b3-imidodiphosphate (AMP-PNP), showed that ATP binding, in the absence of hydrolysis, is sufficient to reduce substrate-binding affinity. Also, ATP binding induces substantial conformational changes in the TMDs. Spectroscopic, protease accessibility and crosslinking studies have shown that ATP binding to the NBDs induces conformational changes in multidrug resistance-associated protein-1 (MRP1), HisPMQ, LmrA, and Pgp. Two dimensional crystal structures of AMP-PNP-bound Pgp showed that the major conformational change during the transport cycle occurs upon ATP binding and that subsequent ATP hydrolysis introduces more limited changes. Rotation and tilting of transmembrane \u03b1-helices may both contribute to these conformational changes. Other studies have focused on confirming that ATP binding induces NBD closed dimer formation. Biochemical studies of intact transport complexes suggest that the conformational changes in the NBDs are relatively small. In the absence of ATP, the NBDs may be relatively flexible, but they do not involve a major reorientation of the NBDs with respect to the other domains. ATP binding induces a rigid body rotation of the two ABC subdomains with respect to each other, which allows the proper alignment of the nucleotide in the active site and interaction with the designated motifs. There is strong biochemical evidence that binding of two ATP molecules can be cooperative, that is, ATP must bind to the two active site pockets before the NBDs can dimerize and form the closed, catalytically active conformation.",
            "score": 81.51276063919067
        },
        {
            "docid": "14762247_5",
            "document": "EGLN1 . PHD2 catalyses the hydroxylation of two sites on HIF-\u03b1, which are termed termed the N-terminal oxygen dependent degradation domain (residues 395-413, NODD) and the C-terminal oxygen dependent degradation domain (residues 556-574, CODD). These two HIF substrates are usually represented by 19 amino acid long peptides in \"in vitro\" experiments. X-ray crystallography and NMR spectroscopy showed that both peptides bind to the same binding site on PHD2, in a cleft on the PHD2 surface. An induced fit mechanism was indicated from the structure, in which residues 237-254 adopt a closed loop conformation, whilst in the structure without CODD or NODD, the same residues adopted an open finger-like conformation. Such conformational change was confirmed by NMR spectroscopy, X-ray crystallography and molecular dynamics calculations. Interestingly, a recent study found a second peptide binding site on PHD2 although peptide binding to this alternative site did not seem to affect the catalytic activity of the enzyme. Further studies are required to fully understand the biological significance of this second peptide binding site.",
            "score": 91.20427823066711
        },
        {
            "docid": "23634_17",
            "document": "Protein . Proteins are not entirely rigid molecules. In addition to these levels of structure, proteins may shift between several related structures while they perform their functions. In the context of these functional rearrangements, these tertiary or quaternary structures are usually referred to as \"conformations\", and transitions between them are called \"conformational changes.\" Such changes are often induced by the binding of a substrate molecule to an enzyme's active site, or the physical region of the protein that participates in chemical catalysis. In solution proteins also undergo variation in structure through thermal vibration and the collision with other molecules.",
            "score": 76.13033628463745
        },
        {
            "docid": "529609_8",
            "document": "Chemical specificity . Aside from interactions, the actual conformation or shape of the enzyme affects what particular substrates are able to bind to it. The enzyme's shape complementarity for its substrate is crucial in ensuring the substrate is in the correct proximity and orientation in order for the enzyme to successfully bind its substrate. These conformational restrictions are known as induced fit and lock-key model.",
            "score": 89.29664707183838
        },
        {
            "docid": "11213645_5",
            "document": "Carboxypeptidase A . Classified as a metalloexopeptidase, carboxypeptidase A consists of a single polypeptide chain bound to a zinc ion. This characteristic metal ion is located within the active site of the enzyme, along with five amino acid residues that are involved in substrate binding: Arg-71, Arg-127, Asn-144, Arg-145, Tyr-248, and Glu-270. X-ray crystallographic studies have revealed five subsites on the protein. These allosteric sites are involved in creating the ligand-enzyme specificity seen in most bioactive enzymes. One of these subsites induces a conformational change at Tyr-248 upon binding of a substrate molecule at the primary active site. The phenolic hydroxyl of tyrosine forms a hydrogen bond with the terminal carboxylate of the ligand. In addition, a second hydrogen bond is formed between the tyrosine and a peptide linkage of longer peptide substrates. These changes make the bond between the enzyme and ligand, whether it is substrate or inhibitor, much stronger. This property of carboxypeptidase A led to the first clause of Daniel E. Koshland, Jr.\u2019s \u201cinduced fit\u201d hypothesis.",
            "score": 92.56623649597168
        },
        {
            "docid": "1731024_12",
            "document": "Tetrahedral carbonyl addition compound . A solvated ligand that binds the protein of interest is likely to exist as an equilibrium mixture of several conformers. Likewise the solvated protein also exists as several conformers in equilibrium. Formation of protein-ligand complex includes displacement of the solvent molecules that occupy the binding site of the ligand, to produce a solvated complex. Because this necessarily means that the interaction is entropically disfavored, highly favorable enthalpic contacts between the protein and the ligand must compensate for the entropic loss. The design of new ligands is usually based on the modification of known ligands for the target proteins. Proteases are enzymes that catalyze hydrolysis of a peptide bond. These proteins have evolved to recognize and bind the transition state of peptide hydrolysis reaction which is a tetrahedral intermediate. Therefore, the main protease inhibitors are tetrahedral intermediate mimics having an alcohol or a phosphate group. Examples are saquinavir, ritonavir, pepstatin, etc.",
            "score": 88.51264476776123
        },
        {
            "docid": "6182049_2",
            "document": "Allosteric enzyme . Allosteric enzymes are enzymes that change their conformational ensemble upon binding of an effector, which results in an apparent change in binding affinity at a different ligand binding site. This \"action at a distance\" through binding of one ligand affecting the binding of another at a distinctly different site, is the essence of the allosteric concept. Allostery plays a crucial role in many fundamental biological processes, including but not limited to cell signaling and the regulation of metabolism. Allosteric enzymes need not be oligomers as previously thought, and in fact many systems have demonstrated allostery within single enzymes. In biochemistry, allosteric regulation (or allosteric control) is the regulation of a protein by binding an effector molecule at a site other than the enzyme's active site.",
            "score": 110.62922525405884
        },
        {
            "docid": "169123_22",
            "document": "Urease . The mechanism proposed by Hausinger and Karplus attempts to revise some of the issues apparent in the Blakely and Zerner pathway, and focuses on the positions of the side chains making up the urea-binding pocket. From the crystal structures from K. aerogenes urease, it was argued that the general base used in the Blakely mechanism, His, was too far away from the Ni2-bound water to deprotonate in order to form the attacking hydroxide moiety. In addition, the general acidic ligand required to protonate the urea nitrogen was not identified. Hausinger and Karplus suggests a reverse protonation scheme, where a protonated form of the His ligand plays the role of the general acid and the Ni2-bound water is already in the deprotonated state. The mechanism follows the same path, with the general base omitted (as there is no more need for it) and His donating its proton to form the ammonia molecule, which is then released from the enzyme. While the majority of the His ligands and bound water will not be in their active forms (protonated and deprotonated, respectively,) it was calculated that approximately 0.3% of total urease enzyme would be active at any one time. While logically, this would imply that the enzyme is not very efficient, contrary to established knowledge, usage of the reverse protonation scheme provides an advantage in increased reactivity for the active form, balancing out the disadvantage. Placing the His ligand as an essential component in the mechanism also takes into account the mobile flap region of the enzyme. As this histidine ligand is part of the mobile flap, binding of the urea substrate for catalysis closes this flap over the active site and with the addition of the hydrogen bonding pattern to urea from other ligands in the pocket, speaks to the selectivity of the urease enzyme for urea.",
            "score": 86.07442057132721
        },
        {
            "docid": "14877966_3",
            "document": "PDK3 . The structure of the PDK3/L2 complex has been elucidated, and there are several key features. When the L2 domain binds to PDK3, it induces a \u201ccross-tail\u201d conformation in PDK3, thereby stimulating activity. There are three crucial residues, Leu-140, Glu-170, and Glu-179, in the C-terminal domain that are crucial for this interaction. Structural studies have indicated that L2 binding stimulates activity by disrupting the closed conformation, or ATP lid, to remove product inhibition. The PDK3 subunits are in one of two conformations; one subunit exists as an \u201copen\u201d subunit, while the other subunit is \u201cclosed\u201d. The open subunit is the configuration most crucial to the putative substrate-binding cleft, as it is where the target peptide can access the active center. The closed subunit blocks this target peptide because of a neighboring unwound alpha helix. Additionally, the ATP-binding loop in one PDK3 subunit adopts an open conformation, implying that the nucleotide loading into the active site is mediated by the inactive \"pre-insertion\" binding mode. This asymmetric complex represents a physiological state in which binding of a single L2-domain activates one of the PDHK subunits while inactivating another. Thus, the L2-domains likely act not only as the structural anchors but also modulate the catalytic cycle of PDK3.",
            "score": 77.72251582145691
        },
        {
            "docid": "1938226_2",
            "document": "Molecular imprinting . In chemistry, molecular imprinting is a technique to create template-shaped cavities in polymer matrices with memory of the template molecules to be used in molecular recognition. This technique is based on the system used by enzymes for substrate recognition, which is called the \"lock and key\" model. The active binding site of an enzyme has a unique geometric structure that is particularly suitable for a substrate. A substrate that has a corresponding shape to the site is recognized by selectively binding to the enzyme, while an incorrectly shaped molecule that does not fit the binding site is not recognized. In a similar way, molecularly imprinted materials are prepared using a template molecule and functional monomers that assemble around the template and subsequently get crosslinked to each other. The functional monomers, which are self-assembled around the template molecule by interaction between functional groups on both the template and monomers, are polymerized to form an imprinted matrix (commonly known in the scientific community as a molecular imprinted polymer i.e. MIP). Then the template molecule is removed from the matrix under certain conditions, leaving behind a cavity complementary in size and shape to the template. The obtained cavity can work as a selective binding site for a specific template molecule.",
            "score": 71.97000670433044
        }
    ],
    "r": [
        {
            "docid": "47331514_13",
            "document": "Alpha-ketoglutarate-dependent hydroxylases . Many assays were developed to study \u03b1KG-dependent dioxygenases so that information such as enzyme kinetics, enzyme inhibition and ligand binding can be obtained. Nuclear magnetic resonance (NMR) spectroscopy is widely applied to study \u03b1KG-dependent dioxygenases. For example, assays were developed to study ligand binding, enzyme kinetics, modes of inhibition as well as protein conformational change. Mass spectrometry is also widely applied. It can be used to characterise enzyme kinetics, to guide enzyme inhibitor development, study ligand and metal binding as well as analyse protein conformational change. Assays using spectrophotometry were also used, for example those that measure 2OG oxidaion, co-product succinate formation or product formation. Other biophysical techniques including (but not limited to) isothermal titration calorimetry (ITC) and electron paramagnetic resonance (EPR) were also applied. Radioactive assays that uses C labelled substrates were also developed and used. Given \u03b1KG-dependent dioxygenases require oxygen for their catalytic activity, oxygen consumption assay was also applied.",
            "score": 114.13875579833984
        },
        {
            "docid": "106256_13",
            "document": "Allosteric regulation . Allosteric modulation is commonly used to alter the activity of molecules and enzymes in biochemistry and pharmacology. For example, drugs are made to bind to the active site of the enzyme which inhibit the substrates to bind to the enzyme and perform the reaction. Allosteric modulation occurs when a specific ligand binds to the allosteric site (also known as the regulatory site) of the enzyme and alters the drugs' effects on the substrates by either activating or inhibiting the enzyme activity. Allosteric modulators are designed to fit the allosteric site to cause conformational changes of the enzyme by changing the shape of the active site which causes a change in its activity. They work regardless of the fact that the enzyme substrate was able to bind to the active site or not. They can be positive,(activating) causing an increase of the enzyme activity, or they can be negative (inhibiting) causing a decrease of the enzyme activity. The use of allosteric modulation allows the control of the effects of specific enzyme activities, as a result, allosteric modulators are very effective in pharmacology.",
            "score": 112.07910919189453
        },
        {
            "docid": "6182049_2",
            "document": "Allosteric enzyme . Allosteric enzymes are enzymes that change their conformational ensemble upon binding of an effector, which results in an apparent change in binding affinity at a different ligand binding site. This \"action at a distance\" through binding of one ligand affecting the binding of another at a distinctly different site, is the essence of the allosteric concept. Allostery plays a crucial role in many fundamental biological processes, including but not limited to cell signaling and the regulation of metabolism. Allosteric enzymes need not be oligomers as previously thought, and in fact many systems have demonstrated allostery within single enzymes. In biochemistry, allosteric regulation (or allosteric control) is the regulation of a protein by binding an effector molecule at a site other than the enzyme's active site.",
            "score": 110.62922668457031
        },
        {
            "docid": "3043886_66",
            "document": "Enzyme kinetics . The favoured model for the enzyme\u2013substrate interaction is the induced fit model. This model proposes that the initial interaction between enzyme and substrate is relatively weak, but that these weak interactions rapidly induce conformational changes in the enzyme that strengthen binding. These conformational changes also bring catalytic residues in the active site close to the chemical bonds in the substrate that will be altered in the reaction. Conformational changes can be measured using circular dichroism or dual polarisation interferometry. After binding takes place, one or more mechanisms of catalysis lower the energy of the reaction's transition state by providing an alternative chemical pathway for the reaction. Mechanisms of catalysis include catalysis by bond strain; by proximity and orientation; by active-site proton donors or acceptors; covalent catalysis and quantum tunnelling.",
            "score": 109.03271484375
        },
        {
            "docid": "39192470_7",
            "document": "Soluble adenylyl cyclase . The open conformation state of sAC is reached when ATP, with Ca bound to its \u03b3-phosphate binds with specific residues in the catalytic center of the enzyme. When the second metal \u2013 a Mg ion \u2013 binds to the \u03b1-phosphate of ATP leads to a conformational change of the enzyme: \"the close state\". The change in conformation from open to close state induces esterification of the \u03b1-phosphate with the ribose in adenosine and the release of the \u03b2- and \u03b3-phosphates, this leads to cyclizing. Hydrogencarbonate stimulates the enzyme\u2019s V by promoting the allosteric change that leads to active site closure, recruitment of the catalytic Mg ion, and readjustment of the phosphates in the bound ATP. The activator bicarbonate binds to a site pseudo-symmetric to the active site and triggers conformational changes by recruiting Arg176 from the active site (see above - \"structure\"). Calcium increases substrate affinity by replacing the magnesium in the ion B site, which provides an anchoring point for the beta- and gamma-phosphates of the ATP substrate.",
            "score": 107.67993927001953
        },
        {
            "docid": "342457_11",
            "document": "Cellulase . Both binding of substrates and catalysis depend on the three-dimensional structure of the enzyme which arises as a consequence of the level of protein folding. The amino acid sequence and arrangement of their residues that occur within the active site, the position where the substrate binds, may influence factors like binding affinity of ligands, stabilization of substrates within the active site and catalysis. The substrate structure is complementary to the precise active site structure of enzyme. Changes in the position of residues may result in distortion of one or more of these interactions. Additional factors like temperature, pH and metal ions influence the non-covalent interactions between enzyme structure. The Thermotoga maritima species make cellulases consisting of 2 beta-sheets (protein structures) surrounding a central catalytic region which is the active-site. The enzyme is categorised as an endoglucanase, which internally cleaves \u03b2-1,4 -glycosydic bonds in cellulose chains facilitating further degradation of the polymer. Different species in the same family as T. Maritima make cellulases with different structures. Cellulases produced by the species Coprinopsis Cinerea consists of seven protein strands in the shape of an enclosed tunnel called a beta/alpha barrel. These enzymes hydrolyse the substrate carboxymethyl cellulose. Binding of the substrate in the active site induces a change in conformation which allows degradation of the molecule.",
            "score": 107.47722625732422
        },
        {
            "docid": "24664397_13",
            "document": "Discovery and development of non-nucleoside reverse-transcriptase inhibitors . The NNRTIs act by binding non-competitively to the RT enzyme (figure 3). The binding causes conformational change in the three-dimensional structure of the enzyme and creates the NNIBP. Binding of NNRTI to HIV-1 RT makes the p66 thumb domain hyper extended because it induces rotamer conformation changes in amino acid residues Tyr-181 and Tyr-188. This affects the catalytic activity of the enzyme and blocks the HIV-1 replication by inhibiting the polymerase active site of the RT's p66 subunit. The global conformational change additionally destabilizes the enzyme on its nucleic acid template and reduces its ability to bind nucleotides. The transcription of the viral RNA is inhibited and therefore the replication rate of the virus reduces. Although the exact molecular mechanism is still hypothetical this has been demonstrated by multiple studies to be the primary mechanism of action.",
            "score": 104.3961181640625
        },
        {
            "docid": "3043886_5",
            "document": "Enzyme kinetics . When enzymes bind multiple substrates, such as dihydrofolate reductase (shown right), enzyme kinetics can also show the sequence in which these substrates bind and the sequence in which products are released. An example of enzymes that bind a single substrate and release multiple products are proteases, which cleave one protein substrate into two polypeptide products. Others join two substrates together, such as DNA polymerase linking a nucleotide to DNA. Although these mechanisms are often a complex series of steps, there is typically one \"rate-determining step\" that determines the overall kinetics. This rate-determining step may be a chemical reaction or a conformational change of the enzyme or substrates, such as those involved in the release of product(s) from the enzyme.",
            "score": 103.24864196777344
        },
        {
            "docid": "8368304_5",
            "document": "Sequential model . The KNF model follows the structural theory of the induced fit model of substrate binding to an enzyme. A slight change in the conformation of an enzyme improves its binding affinity to the transition state of the ligand, thus catalyzing a reaction. This follows the KNF model, which models cooperativity as the changing conformation of the ligand binding site upon ligand binding to another subunit.",
            "score": 102.0638656616211
        },
        {
            "docid": "5464960_35",
            "document": "Enzyme inhibitor . Not all irreversible inhibitors form covalent adducts with their enzyme targets. Some reversible inhibitors bind so tightly to their target enzyme that they are essentially irreversible. These tight-binding inhibitors may show kinetics similar to covalent irreversible inhibitors. In these cases, some of these inhibitors rapidly bind to the enzyme in a low-affinity EI complex and this then undergoes a slower rearrangement to a very tightly bound EI* complex (see figure above). This kinetic behaviour is called slow-binding. This slow rearrangement after binding often involves a conformational change as the enzyme \"clamps down\" around the inhibitor molecule. Examples of slow-binding inhibitors include some important drugs, such methotrexate, allopurinol, and the activated form of acyclovir.",
            "score": 101.96004486083984
        },
        {
            "docid": "3043886_55",
            "document": "Enzyme kinetics . Traditionally reversible enzyme inhibitors have been classified as competitive, uncompetitive, or non-competitive, according to their effects on \"K\" and \"V\". These different effects result from the inhibitor binding to the enzyme E, to the enzyme\u2013substrate complex ES, or to both, respectively. The division of these classes arises from a problem in their derivation and results in the need to use two different binding constants for one binding event. The binding of an inhibitor and its effect on the enzymatic activity are two distinctly different things, another problem the traditional equations fail to acknowledge. In noncompetitive inhibition the binding of the inhibitor results in 100% inhibition of the enzyme only, and fails to consider the possibility of anything in between. In noncompetitive inhibition, the inhibitor will bind to an enzyme at its allosteric site; therefore, the binding affinity, or Km, of the substrate with the enzyme will remain the same. On the other hand, the Vmax will decrease relative to an uninhibited enzyme. On a Lineweaver-Burk plot, the presence of a noncompetitive inhibitor is illustrated by a change in the y-intercept, defined as 1/Vmax. The x-intercept, defined as -1/Km, will remain the same. In competitive inhibition, the inhibitor will bind to an enzyme at the active site, competing with the substrate. As a result, the Km will increase and the Vmax will remain the same. The common form of the inhibitory term also obscures the relationship between the inhibitor binding to the enzyme and its relationship to any other binding term be it the Michaelis\u2013Menten equation or a dose response curve associated with ligand receptor binding. To demonstrate the relationship the following rearrangement can be made:",
            "score": 101.70171356201172
        },
        {
            "docid": "188688_10",
            "document": "Active site . Daniel Koshland's theory of enzyme-substrate binding is that the active site and the binding portion of the substrate are not exactly complementary. The induced fit model is a development of the lock-and-key model and assumes that an active site is flexible and changes shape until the substrate is completely bound. This model is similar to a person wearing a glove: it changes shape to fit the hand. The enzyme initially has a configuration that attracts its substrate. Enzyme surface is flexible and only the correct catalyst can induce interaction leading to catalysis. Conformational changes may then occur as the substrate is bound. After the reaction products will move away from the enzyme and the active site returns to its initial shape. This hypothesis is supported by the observation that the entire protein domain could move several nanometers during catalysis. This movement of protein surface can create microenvironments that favour the catalysis.",
            "score": 99.69319152832031
        },
        {
            "docid": "51903_14",
            "document": "Tyrosine kinase . Major changes are sometimes induced when the tyrosine kinase enzyme is affected by other factors. One of the factors is a molecule that is bound reversibly by a protein, called a ligand. A number of receptor tyrosine kinases, though certainly not all, do not perform protein-kinase activity until they are occupied, or activated, by one of these ligands. It is interesting to note that, although many more recent cases of research indicate that receptors remain active within endosomes, it was once thought that endocytosis caused by ligands was the event responsible for the process in which receptors are inactivated. Activated receptor tyrosine kinase receptors are internalized (recycled back into the system) in short time and are ultimately delivered to lysosomes, where they become work-adjacent to the catabolic acid hydrolases that partake in digestion. Internalized signaling complexes are involved in different roles in different receptor tyrosine kinase systems, the specifics of which were researched. In addition, ligands participate in reversible binding, a term that describes those inhibitors that bind non-covalently (inhibition of different types are effected depending on whether these inhibitors bind the enzyme, the enzyme-substrate complex, or both). Multivalency, which is an attribute that bears particular interest to some people involved in related scientific research, is a phenomenon characterized by the concurrent binding of several ligands positioned on one unit to several coinciding receptors on another. In any case, the binding of the ligand to its partner is apparent owing to the effects that it can have on the functionality of many proteins. Ligand-activated receptor tyrosine kinases, as they are sometimes referred to, demonstrate a unique attribute. Once a tyrosine receptor kinase is bonded to its ligand, it is able to bind to tyrosine kinase residing in the cytosol of the cell.",
            "score": 99.51991271972656
        },
        {
            "docid": "11402986_5",
            "document": "Deoxycytidine kinase . One method of to regulate both catalytic activity and substrate specificity is a post-translational modification on Serine 74, a residue in the insert region on each of the individual dCK subunits. Although serine 74 is far from dCK's active site, phosphorylation of serine 74 (Ser74) on dCK causes a change in enzyme conformation and influences enzyme kinetics. More specifically, phosphorylation of Ser74 favors dCK to adopt its open (inactive) conformation and allow dCK to become more competent in binding and releasing nucleosides but restricts dCK from transferring phosphoryl groups. dCK's closed (active) conformation allows dCK to transfer phosphoryl groups, but not bind or release nucleosides. The \"open\" and \"closed\" states refer to the nucleoside binding site on dCK.",
            "score": 98.90247344970703
        },
        {
            "docid": "1908538_6",
            "document": "CGMP-specific phosphodiesterase type 5 . PDE5 is an enzyme that accepts cGMP and breaks it down. Sildenafil, vardenafil and tadalafil are inhibitors of this enzyme, which bind to the catalytic site of PDE5. Both inhibitors bind with high affinity and specificity, and cGMP-binding to the allosteric sites stimulates binding of PDE5 inhibitors at the catalytic site. The kinetics of inhibitor binding and inhibition of catalysis imply the existence of two PDE5 comformers, and results of native gel electrophoresis reveal that PDE5 exists in two apparently distinct conformations, i.e., an extended conformer and a more compact conformer.",
            "score": 98.63583374023438
        },
        {
            "docid": "8368304_2",
            "document": "Sequential model . The sequential model (also known as the KNF model ) is a theory that describes cooperativity of protein subunits It postulates that a protein's conformation changes with each binding of a ligand, thus sequentially changing its affinity for the ligand at neighboring binding sites.  This model for allosteric regulation of enzymes suggests that the subunits of multimeric proteins have two conformational states. The binding of the ligand causes conformational change in the other subunits of the multimeric protein. Although the subunits go through conformational changes independently (as opposed to in the MWC model), the switch of one subunit makes the other subunits more likely to change, by reducing the energy needed for subsequent subunits to undergo the same conformational change. In elaboration, the binding of a ligand to one subunit changes the protein's shape, thereby making it more thermodynamically favorable for the other subunits to switch conformation to the high affinity state. Ligand binding may also result in negative cooperativity, or a reduced affinity for the ligand at the next binding site, a feature that makes the KNF model distinct from the MWC model, which suggests only positive cooperativity. It is named KNF after Koshland, N\u00e9methy and Filmer, who first suggested the model .",
            "score": 97.48777770996094
        },
        {
            "docid": "32270776_4",
            "document": "Citrate synthase family . Citrate synthase enzymes are found in two distinct structural types: type I enzymes (found in eukaryotes, Gram-positive bacteria and archaea) form homodimers and have shorter sequences than type II enzymes, which are found in Gram-negative bacteria and are hexameric in structure. In both types, the monomer is composed of two domains: a large alpha-helical domain consisting of two structural repeats, where the second repeat is interrupted by a small alpha-helical domain. The cleft between these domains forms the active site, where both citrate and acetyl-coenzyme A bind. The enzyme undergoes a conformational change upon binding of the oxaloacetate ligand, whereby the active site cleft closes over in order to form the acetyl-CoA binding site. The energy required for domain closure comes from the interaction of the enzyme with the substrate. Type II enzymes possess an extra N-terminal beta-sheet domain, and some type II enzymes are allosterically inhibited by NADH.",
            "score": 97.08216094970703
        },
        {
            "docid": "31726766_10",
            "document": "Nanoparticle\u2013biomolecule conjugate . Biological processes can be controlled through transcription regulation, gene regulation, and enzyme inhibition processes that can be regulated using nanoparticles. Nanoparticles can play a part in gene regulation through ionic bonding between positively charged cationic ligands on the surfaces of nanoparticles and negatively charged anionic nucleic acids present in DNA. In an experiment, a nanoparticle-DNA complex inhibited transcription by T7 RNA polymerase, signifying strong bonding in the complex. A high affinity of the nanoparticle-DNA complex indicates strong bonding and a favorable use of nanoparticles. Attaching ionic ligands to nanoparticles allows control over enzyme activity. An example of enzyme inhibition is given by binding of a-chymotrypsin (ChT), an enzyme with a largely cationic active site. When a-chymotrypsin is incubated with anionic (negatively charged) nanoparticles, ChT activity is inhibited as anionic nanoparticles bind to the active site. Enzyme activity can be restored by the addition of cationic surfactants. Alkyl surfactants form a bilayer around ChT, whereas thiol and alcohol surfactants alter the surface of ChT such that interactions with nanoparticles are interrupted. Though formation of a protein-nanoparticle complex can inhibit enzyme activity, studies show that it can also stabilize protein structure, and significantly protect the protein from denaturization. Attachments of ligands to segments of nanoparticles selected for functionalization of metallic properties can be used to generate a magnetic nanowire, which generates a magnetic field that allows for the manipulation of cellular assemblies.",
            "score": 97.03556823730469
        },
        {
            "docid": "2764033_12",
            "document": "DNA polymerase II . Upon binding of substrate, DNA Pol II binds nucleoside triphosphates to maintain the hydrogen bonded structure of DNA. The correct dNTP is then bound and the enzyme complex undergoes conformational changes of subdomains and amino acid residues. These conformational changes allow the rate of repair synthesis to be fast. The active site contains two Mg ions that are stabilized by catalytic Aspartic Acids D419 and D547. Magnesium ions bind to DNA along with dNTP in the open state and coordinate conformational changes of active site amino acid residues in order for catalysis to take place (closed state). After magnesium ions are released, the enzyme returns to its open state.",
            "score": 95.99395751953125
        },
        {
            "docid": "38854799_9",
            "document": "Alpha-D-phosphohexomutase superfamily . Structural studies of P. aeruginosa PMM/PGM by X-ray crystallography have been conducted as both apo-enzyme and as protein-ligand complexes. Based on these studies, it has been seen that when the sugar substrate binds to the enzyme there is a rotation in the C-terminal domain of the protein. This changes the active site from an open cleft in the apo-enzyme into a nearly solvent inaccessible pocket. This theme of conformational flexibility, particularly with regard to the C-terminal domain of these enzymes, has been observed in multiple proteins in the superfamily.",
            "score": 94.66197204589844
        },
        {
            "docid": "910418_9",
            "document": "Plasmin . In closed plasminogen, access to the activation bond (R561/V562) targeted for cleavage by tPA and uPA is blocked through the position of the KR3/KR4 linker sequence and the O-linked sugar on T346. The position of KR3 may also hinder access to the activation loop. The Inter-domain interactions also block all kringle ligand-binding sites apart from that of KR-1, suggesting that the latter domain governs pro-enzyme recruitment to targets. Analysis of an intermediate plasminogen structure suggests that plasminogen conformational change to the open form is initiated through KR-5 transiently peeling away from the PAp domain. These movements expose the KR5 lysine-binding site to potential binding partners, and suggest a requirement for spatially distinct lysine residues in eliciting plasminogen recruitment and conformational change respectively.",
            "score": 94.01190948486328
        },
        {
            "docid": "31881102_3",
            "document": "Lead Finder . Lead-Finder software is an integrated solution for simulating structure and binding affinity of protein-ligand complexes. The software combines automatic processing of protein structures, extra precision protein-ligand docking and calculation of free energy of ligand binding. Original docking algorithm provides a fast rate of calculations, which can be easily adjusted from more rapid (for virtual screening applications) to slightly more slow and robust, while unique scoring function implemented in Lead-Finder provides unsurpassed accuracy of calculations.  Lead-Finder is intended to meet the requirements of computational and medicinal chemists involved in drug discovery, pharmacologists and toxicologists involved in the evaluation of ADMET properties in silico, and biochemists and enzymologists working on modeling protein-ligand interactions, enzyme specificity and rational enzyme design. Efficiency of ligand docking and binding energy estimations achieved by Lead-Finder are due to docking algorithm and extra precision representation of protein-ligand interactions.",
            "score": 93.72737121582031
        },
        {
            "docid": "2679839_9",
            "document": "Transketolase . In the first half of this pathway, His263 is used to effectively abstract the C3 hydroxyl proton, which thus allows a 2-carbon segment to be cleaved from fructose 6-phosphate. The cofactor necessary for this step to occur is thiamin pyrophosphate (TPP). The binding of TPP to the enzyme incurs no major conformational change to the enzyme; instead, the enzyme has two flexible loops at the active site that make TPP accessible and binding possible. Thus, this allows the active site to have a \"closed\" conformation rather than a large conformational change. Later in the pathway, His263 is used as a proton donor for the substrate acceptor-TPP complex, which can then generate erythrose-4-phosphate.",
            "score": 93.65589141845703
        },
        {
            "docid": "5464960_40",
            "document": "Enzyme inhibitor . More recently, an alternative approach has been applied: rational drug design uses the three-dimensional structure of an enzyme's active site to predict which molecules might be inhibitors. These predictions are then tested and one of these tested compounds may be a novel inhibitor. This new inhibitor is then used to try to obtain a structure of the enzyme in an inhibitor/enzyme complex to show how the molecule is binding to the active site, allowing changes to be made to the inhibitor to try to optimise binding. This test and improve cycle is then repeated until a sufficiently potent inhibitor is produced. Computer-based methods of predicting the affinity of an inhibitor for an enzyme are also being developed, such as molecular docking and molecular mechanics.",
            "score": 93.35112762451172
        },
        {
            "docid": "14216616_7",
            "document": "Phosphoenolpyruvate mutase . However, more recently, a structure with a sulfopyruvate inhibitor, which is a closer substrate analogue, was solved (); this study supported instead a dissociative mechanism. A notable feature of these structures was the shielding of the active site from solvent; it was proposed that a significant conformational change takes place on binding to allow this, moving the protein from an \"open\" to a \"closed\" state, and this was supported by several crystal structures in the open state. Three of these were of the wild type: the apoenzyme in , the enzyme plus its magnesium ion cofactor in , and the enzyme at high ionic strength in . A mutant (D58A, in one of the active-site loops) was crystallized as an apoenzyme also (). From these structures, an active-site \"gating\" loop (residues 115-133) that shields the substrate from solvent in the closed conformation was identified.",
            "score": 93.3366928100586
        },
        {
            "docid": "5464960_14",
            "document": "Enzyme inhibitor . Traditionally reversible enzyme inhibitors have been classified as competitive, uncompetitive, or non-competitive, according to their effects on \"K\" and \"V\". These different effects result from the inhibitor binding to the enzyme E, to the enzyme\u2013substrate complex ES, or to both, respectively. The division of these classes arises from a problem in their derivation and results in the need to use two different binding constants for one binding event. The binding of an inhibitor and its effect on the enzymatic activity are two distinctly different things, another problem the traditional equations fail to acknowledge. In noncompetitive inhibition the binding of the inhibitor results in 100% inhibition of the enzyme only, and fails to consider the possibility of anything in between. The common form of the inhibitory term also obscures the relationship between the inhibitor binding to the enzyme and its relationship to any other binding term be it the Michaelis\u2013Menten equation or a dose response curve associated with ligand receptor binding. To demonstrate the relationship the following rearrangement can be made:",
            "score": 93.26830291748047
        },
        {
            "docid": "8258312_4",
            "document": "Ubiquitin-activating enzyme . At the start of the ubiquitination cascade, the E1 enzyme (Figure 2) binds ATP-Mg and ubiquitin and catalyses ubiquitin C-terminal acyl adenylation. In the next step a catalytic cysteine (Figure 3) on the E1 enzyme attacks the ubiquitin-AMP complex through acyl substitution, simultaneously creating a thioester bond and an AMP leaving group. Finally, the E1~ubiquitin complex transfers ubiquitin to an E2 enzyme through a transthioesterification reaction, in which an E2 catalytic cysteine attacks the backside of the E1~ubiquitin complex. However, the transthioesterification process is very complicated, as both E1 and E2 enzymes form an intermediate complex wherein both enzymes undergo a series of conformational changes in order to bind with one another.",
            "score": 92.68601989746094
        },
        {
            "docid": "11213645_5",
            "document": "Carboxypeptidase A . Classified as a metalloexopeptidase, carboxypeptidase A consists of a single polypeptide chain bound to a zinc ion. This characteristic metal ion is located within the active site of the enzyme, along with five amino acid residues that are involved in substrate binding: Arg-71, Arg-127, Asn-144, Arg-145, Tyr-248, and Glu-270. X-ray crystallographic studies have revealed five subsites on the protein. These allosteric sites are involved in creating the ligand-enzyme specificity seen in most bioactive enzymes. One of these subsites induces a conformational change at Tyr-248 upon binding of a substrate molecule at the primary active site. The phenolic hydroxyl of tyrosine forms a hydrogen bond with the terminal carboxylate of the ligand. In addition, a second hydrogen bond is formed between the tyrosine and a peptide linkage of longer peptide substrates. These changes make the bond between the enzyme and ligand, whether it is substrate or inhibitor, much stronger. This property of carboxypeptidase A led to the first clause of Daniel E. Koshland, Jr.\u2019s \u201cinduced fit\u201d hypothesis.",
            "score": 92.56623840332031
        },
        {
            "docid": "3660376_13",
            "document": "Protein contact map . The cytochrome P450s (P450s) are xenobiotic-metabolizing membrane-bound heme-containing enzymes that use molecular oxygen and electrons from NADPH cytochrome P450 reductase to oxidize their substrates. CYP2B4, a member of the cytochrome P450 family is the only protein within this family, whose X-ray structure in both open 11 and closed form 12 is published. The comparison of the open and closed structures of CYP2B4 structures reveals large-scale conformational rearrangement between the two states, with the greatest conformational change around the residues 215-225, which is widely open in ligand-free state and shut after ligand binding; and the region around loop C near the heme.",
            "score": 92.54448699951172
        },
        {
            "docid": "1904560_6",
            "document": "BRENDA . The database contains more than 40 data fields with enzyme-specific information on more than 7000 EC numbers that are classified according to the IUBMB. The different data fields cover information on the enzyme's nomenclature, reaction and specificity, enzyme structure, isolation and preparation, enzyme stability, kinetic parameters such as Km value and turnover number, occurrence and localization, mutants and engineered enzymes, application of enzymes and ligand-related data. Currently, BRENDA contains manually annotated data from over 140,000 different scientific articles. Each enzyme entry is clearly linked to at least one literature reference, to its source organism, and, where available, to the protein sequence of the enzyme. An important part of BRENDA represent the more than 110,000 enzyme ligands, which are available on their names, synonyms or via the chemical structure. The term \"ligand\" is used in this context to all low molecular weight compounds which interact with enzymes. These include not only metabolites of primary metabolism, co-substrates or cofactors but also enzyme inhibitors or metal ions. The origin of these molecules ranges from naturally occurring antibiotics to synthetic compounds that have been synthesized for the development of drugs or pesticides. Furthermore, cross-references to external information resources such as sequence and 3D-structure databases, as well as biomedical ontologies, are provided.",
            "score": 92.37449645996094
        },
        {
            "docid": "4472357_2",
            "document": "ATP-binding motif . An ATP, adenosine triphosphate, binding motif is a 250 residue sequence within an ATP binding protein\u2019s primary structure. The binding motif is associated with a protein\u2019s structure and/or function. ATP is a molecule of energy, and can be a coenzyme, involved in a number of biological reactions. ATP is proficient at interacting with other molecules through a binding site. The ATP binding site is the environment in which ATP catalytically actives the enzyme and, as a result, is hydrolyzed to ADP. The binding of ATP causes a conformational change to the enzyme it is interacting with.",
            "score": 92.04558563232422
        },
        {
            "docid": "582189_4",
            "document": "Competitive inhibition . In competitive inhibition, an inhibitor that resembles the normal substrate binds to the enzyme, usually at the active site, and prevents the substrate from binding. At any given moment, the enzyme may be bound to the inhibitor, the substrate, or neither, but it cannot bind both at the same time. During competitive inhibition, the inhibitor and substrate compete for the active site. The active site is a region on an enzyme which a particular protein or substrate can bind to. The active site will only allow one of the two complexes to bind to the site therefore either allowing for a reaction to occur or yielding it. In competitive inhibition the inhibitor resembles the substrate therefore taking its place and binding to the active site of an enzyme. Increasing the substrate concentration would diminish the \u201ccompetition\u201d for the substrate to properly bind to the active site and allow a reaction to occur. When the substrate is of higher concentration than that of the competitive inhibitor, it is more likely that the substrate will come into contact with the enzyme\u2019s active site than the inhibitor.",
            "score": 91.90583038330078
        }
    ]
}